01 1Cambrex Profarmaco Milano S. r. l.
02 1F. I. S. Fabrica Italiana Sintetici S. p. A.
01 2Lorazepam
01 1Italy
02 1U.S.A
Registration Number : 218MF10781
Registrant's Address : Via Curiel 34, 20067 Paulo, Milano, ITALY
Initial Date of Registration : 2006-09-22
Latest Date of Registration : 2020-11-26
Registration Number : 217MF10849
Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy
Initial Date of Registration : 2005-11-01
Latest Date of Registration : 2009-04-14
A Lorazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lorazepam, including repackagers and relabelers. The FDA regulates Lorazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lorazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lorazepam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lorazepam supplier is an individual or a company that provides Lorazepam active pharmaceutical ingredient (API) or Lorazepam finished formulations upon request. The Lorazepam suppliers may include Lorazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Lorazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Lorazepam Drug Master File in Japan (Lorazepam JDMF) empowers Lorazepam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Lorazepam JDMF during the approval evaluation for pharmaceutical products. At the time of Lorazepam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Lorazepam suppliers with JDMF on PharmaCompass.
We have 2 companies offering Lorazepam
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
